• Find people
• Intranet

Integrative biomedical informatics Ferran Sanz

This group led by Ferran Sanz promotes and tackles synergistic and integrative strategies for affording biomedical problems, making use of approaches developed within the group but also in collaboration with research groups of the GRIB. The current research lines of the Integrative Biomedical Informatics (IBI) are:

1.- Development of new strategies and tools for knowledge extraction and linkage from biomedical literature and other publicly available sources.

2.- Network biology for the study of human diseases and drug toxicity

3.- Integrative knowledge management and exploitation in drug discovery and development, including multi-level and multi-scale modelling and simulation.

The group is currently coordinator of a European project funded by IMI, eTRANSAFE: "Enhancing Translational Safety Assessment through Integrative Knowledge Management" and participates in several European IMI projects such as EHDEN, FAIRplus, TransQST as well as some projects funded by the European Horizon 2020 program such as: RISK-HUNT3R, Disc4All and EU-ToxRisk. In addition, the group participates in various projects financed by Spanish entities.

Other examples of projects in which the group has participated or coordinated recently are: iPiE, EMIF, MedBioinformatics, ELIXIR-EXCELERATE, eTOX, OpenPHACTS, INBIOMEDvision, among others.

In February 2021, some members of the group have established the company MedBioinformatics Solutions, in order to exploit biomedical databases to support drug discovery processes and improve biomedical research.